Department of Health Statistics, School of Public Health, Dalian Medical University, No. 9 South Road, Lvshun District, Dalian 116044, China.
Department of Epidemiology, School of Public Health, Dalian Medical University, No. 9 South Road, Lvshun District, Dalian 116044, China.
Nutrients. 2023 Mar 15;15(6):1415. doi: 10.3390/nu15061415.
Many studies have explored the efficacy of probiotics on autism spectrum disorder (ASD) in children, but there is no consensus on the curative effect. This systematic review and meta-analysis aimed to comprehensively investigate whether probiotics could improve behavioral symptoms in children with ASD. A systematic database search was conducted and a total of seven studies were included in the meta-analysis. We found a nonsignificant overall effect size of probiotics on behavioral symptoms in children with ASD (SMD = -0.24, 95% CI: -0.60 to 0.11, = 0.18). However, a significant overall effect size was found in the subgroup of the probiotic blend (SMD = -0.42, 95% CI: -0.83 to -0.02, = 0.04). Additionally, these studies provided limited evidence for the efficacy of probiotics due to their small sample sizes, a shorter intervention duration, different probiotics used, different scales used, and poor research quality. Thus, randomized, double-blind, and placebo-controlled studies following strict trial guidelines are needed to precisely demonstrate the therapeutic effects of probiotics on ASD in children.
许多研究都探讨了益生菌对儿童自闭症谱系障碍(ASD)的疗效,但对于其疗效尚无共识。本系统评价和荟萃分析旨在全面研究益生菌是否能改善 ASD 儿童的行为症状。系统地进行了数据库检索,共有 7 项研究纳入荟萃分析。我们发现益生菌对 ASD 儿童行为症状的总体效应大小无统计学意义(SMD = -0.24,95%CI:-0.60 至 0.11, = 0.18)。然而,在益生菌混合制剂亚组中发现了显著的总体效应大小(SMD = -0.42,95%CI:-0.83 至 -0.02, = 0.04)。此外,由于这些研究的样本量小、干预持续时间短、使用的益生菌不同、使用的量表不同以及研究质量较差,这些研究为益生菌的疗效提供的证据有限。因此,需要遵循严格试验指南的随机、双盲、安慰剂对照研究来精确证明益生菌对儿童 ASD 的治疗效果。